Join a (MASH) Fatty Liver Disease Research Study
Currently enrolling participants in a Fatty Liver Disease research study. Your participation could help researchers develop new treatments.
Why You Should Join
- Gain access to innovative medical care
- Receive no-cost, study-related care from our medical team
- Help us create a new way to treat this condition for the countless people who need it
- Qualified participants may earn up to $720
A clinical trial is a carefully designed research study involving human volunteers to investigate the safety and effectiveness of a new drug or treatment. Clinical trials are essential for evaluating the benefits and risks of medical interventions, ultimately informing healthcare decisions and regulatory approvals.
As a clinical trial or observational study participant, your responsibilities and what you will be required to do can vary depending on the study, its objectives, and the phase of the trial.
Some common activities and responsibilities you may encounter as a participant include: diagnostic tests, treatments, procedures, doctor visits, dietary changes, exercise and/or other lifestyle changes. Observational studies often involve minimal effort, such as completing questionnaires, sharing test results, maintaining a diet or exercise log.
Joining a clinical trial can provide access to cutting-edge treatments, close medical monitoring, and an opportunity to contribute to medical knowledge. Participants may experience improved health outcomes and specialized care while potentially receiving compensation for volunteering.
Clinical trials are designed with a strong emphasis on the safety of participants, and multiple safeguards are in place to minimize risks, including careful study design, oversight by institutional review boards and routine monitoring of study data by independent experts. Researchers must inform participants of the risks, benefits and/or side effects they discover.
Yes, you can drop out of a clinical trial study at any time, and you have the right to do so without facing any penalties or consequences. This is often referred to as "withdrawal of consent."
Voluntary participation is a fundamental principle of clinical research. You are not obligated to continue in a trial if you no longer wish to do so.
Determining your eligibility to participate in a clinical trial involves a thorough evaluation of specific eligibility criteria set forth by the study's researchers and sponsors. The criteria help define the patient population being studied and are designed to protect the safety of participants in the trial.
Providing accurate information about your medical history and health status is crucial for your safety and the integrity of the research. If you are not eligible for one trial, you may still be eligible for other trials in the future, so it's worth exploring your options if you are interested in participating in clinical research.
Who Can Join
- Age 18 or older
- Has fatty liver disease (specifically Metabolic dysfunction-associated steatohepatitis), which a doctor will confirm with tests like a biopsy or FibroScan
- Generally stable (good kidney function, some blood tests like liver enzymes are only slightly high)
- BMI is between 25 and 50 (Check Your BMI Below ⬇️)
- Does NOT have other liver diseases, such as cirrhosis, liver failure, liver cancer, hepatitis, or a liver transplant
- Does NOT have heart or blood issues, such as high blood pressure, too high a dose of cholesterol medication (statins), uncontrolled arrhythmia, stroke, heart attack, severe heart failure, or heart surgery in the last 6 months
- Does NOT have diabetes (type 1 diabetes or severe type 2 diabetes)
- Does NOT have other serious illnesses, such as autoimmune disease, severe mental illness, or an unstable thyroid/adrenal gland problem
*Other criteria may apply.
Not sure if you qualify? That’s okay.
A member of our recruitment team will review your medical history and medications with you to see if this study may be right for you.
About the Study
This study is researching potential new treatments for fatty liver disease, also known as metabolic dysfunction-associated steatohepatitis (MASH). This condition occurs when fat builds up in the liver and may lead to inflammation and liver damage over time. It is often linked to conditions like high blood pressure, diabetes, or weight-related health concerns.
Researchers are evaluating two investigational treatments, both individually and in combination, to see how they may help improve liver health. These treatments are designed to target how the body processes fat and inflammation.
Participants in this study will receive an active study treatment. There is no placebo group, and researchers will compare how different treatment approaches work.
The goal of this study is to determine whether these treatments are safe and effective in improving liver health and reducing the impact of fatty liver disease.
What to Expect
Study Duration
Approximately 20 weeks
Study Visits
About 7 visits throughout the study
Compensation
- Participants may receive compensation up to $720 for completed study visits.
- Additional reimbursement may be provided for travel expenses with receipts.
Procedures During the Study
- Receive one of the study treatments
- Regular monitoring of liver health and overall wellness
- Blood tests and routine health assessments
- Review of medications and lifestyle factors
- Ongoing support and guidance from the study team